Phase I study with the HER1 / VSSP therapeutic vaccine in patients with hormone-castration-resistant prostate cancer, advanced squamous cell carcinoma of the head and neck and colon cancer

Trial Profile

Phase I study with the HER1 / VSSP therapeutic vaccine in patients with hormone-castration-resistant prostate cancer, advanced squamous cell carcinoma of the head and neck and colon cancer

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Dec 2017

At a glance

  • Drugs HER-1 vaccine Center of Molecular Immunology (Primary)
  • Indications Colon cancer; Head and neck cancer; Prostate cancer; Squamous cell cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top